BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20932085)

  • 21. Proteomic diagnosis models from serum for early detection of oral squamous cell carcinoma.
    Sun G; He H; Ping F; Zhang F
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(3):125-9. PubMed ID: 19412825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
    Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
    Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Search for the tumor-associated proteins of oral squamous cell carcinoma collected in Taiwan using proteomics strategy.
    Liao KA; Tsay YG; Huang LC; Huang HY; Li CF; Wu TF
    J Proteome Res; 2011 May; 10(5):2347-58. PubMed ID: 21322651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary metabolite signatures of oral cancer and leukoplakia.
    Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
    Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
    Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
    Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia.
    Ohkura S; Kondoh N; Hada A; Arai M; Yamazaki Y; Sindoh M; Takahashi M; Matsumoto I; Yamamoto M
    Oral Oncol; 2005 Jul; 41(6):607-13. PubMed ID: 15975524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant proteins in the saliva of patients with oral squamous cell carcinoma.
    Jessie K; Jayapalan JJ; Ong KC; Abdul Rahim ZH; Zain RM; Wong KT; Hashim OH
    Electrophoresis; 2013 Sep; 34(17):2495-502. PubMed ID: 23784731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in mast cells in oral squamous cell carcinoma: possible failure in the migration of these cells.
    Oliveira-Neto HH; Leite AF; Costa NL; Alencar RC; Lara VS; Silva TA; Leles CR; Mendonça FE; Batista AC
    Oral Oncol; 2007 May; 43(5):484-90. PubMed ID: 16979374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of survivin mRNA in healthy oral mucosa, oral leucoplakia and oral cancer.
    Lodi G; Franchini R; Bez C; Sardella A; Moneghini L; Pellegrini C; Bosari S; Manfredi M; Vescovi P; Carrassi A
    Oral Dis; 2010 Jan; 16(1):61-7. PubMed ID: 19732355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ¹H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma.
    Gupta A; Gupta S; Mahdi AA
    Clin Chim Acta; 2015 Feb; 441():47-55. PubMed ID: 25499120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
    Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
    Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study.
    Babiuch K; Bednarczyk A; Gawlik K; Pawlica-Gosiewska D; Kęsek B; Darczuk D; Stępień P; Chomyszyn-Gajewska M; Kaczmarzyk T
    Acta Odontol Scand; 2019 Aug; 77(6):408-418. PubMed ID: 30857448
    [No Abstract]   [Full Text] [Related]  

  • 34. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
    Liu HW; Hu BQ; Cao CF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The expression of urokinase-type plasminogen activator in oral squamous cell carcinoma].
    Liang X; Mao Z; He Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):147-9. PubMed ID: 12838705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study.
    Patel S; Metgud R
    J Cancer Res Ther; 2015; 11(1):119-23. PubMed ID: 25879348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: A preliminary study.
    Bagan JV; Jiménez Y; Murillo J; Poveda R; Díaz JM; Gavaldá C; Margaix M; Scully C; Alberola TM; Torres Puente M; Pérez Alonso M
    Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E110-3. PubMed ID: 18223526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
    Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS
    Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining.
    Lo WY; Lai CC; Hua CH; Tsai MH; Huang SY; Tsai CH; Tsai FJ
    J Proteome Res; 2007 Jun; 6(6):2143-51. PubMed ID: 17451265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions.
    Acay RR; dos Santos E; de Sousa SO
    Oral Oncol; 2008 Jul; 44(7):698-702. PubMed ID: 18061529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.